Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis - PubMed (original) (raw)
. 2007 Jan 1;195(1):70-80.
doi: 10.1086/509821. Epub 2006 Nov 22.
Affiliations
- PMID: 17152010
- DOI: 10.1086/509821
Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis
Michael Hogardt et al. J Infect Dis. 2007.
Abstract
Background: Pseudomonas aeruginosa (PA) strains with defective DNA mismatch repair genes generate numerous bacterial variants because of high mutation rates. In cystic fibrosis (CF), such mutator strains may lead to the rapid selection of survivors that are specifically adapted to the hostile environment of the inflamed CF lung.
Methods: Genotypes and phenotypes of 111 PA variants descending from 3 distinct mutator strains obtained from 3 patients with CF were systematically characterized.
Results: We demonstrated that PA mutS isolates accumulated in the CF lung during the observation period of 3-6 years, with dominance during the final stage of the disease. Mutator strains from the final stage of disease were multiresistant and had lost a set of established virulence-associated traits, including cytotoxicity for bronchial epithelial cells (Calu-3) and macrophages (J774). This pathoadaptation was associated with the loss of survival capacity in a typical environmental habitat, such as tap water. Strikingly, nonmutator strains that maintained their virulence potential persisted as a minority, probably with a preference for the lower airways.
Conclusions: Mutator strains may evolve from the initially infecting PA strain and generate numerous variants with a loss of destructive virulence factors, probably because of selection for improved survival in the deteriorated CF lung but at the expense of the ability to live freely.
Similar articles
- Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S, Imhof A, Heesemann J, Hogardt M. Hoboth C, et al. J Infect Dis. 2009 Jul 1;200(1):118-30. doi: 10.1086/599360. J Infect Dis. 2009. PMID: 19459782 - Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
Ciofu O, Riis B, Pressler T, Poulsen HE, Høiby N. Ciofu O, et al. Antimicrob Agents Chemother. 2005 Jun;49(6):2276-82. doi: 10.1128/AAC.49.6.2276-2282.2005. Antimicrob Agents Chemother. 2005. PMID: 15917521 Free PMC article. - Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R, Champion A, Reid DW. Bradbury R, et al. Respirology. 2008 Nov;13(6):886-92. doi: 10.1111/j.1440-1843.2008.01383.x. Respirology. 2008. PMID: 18811887 - Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B, Bosshammer J, Breitenstein S, Brockhausen I, Gudowius P, Herrmann C, Herrmann S, Heuer T, Kubesch P, Mekus F, Römling U, Schmidt KD, Spangenberg C, Walter S. Tümmler B, et al. Behring Inst Mitt. 1997 Feb;(98):249-55. Behring Inst Mitt. 1997. PMID: 9382747 Review. - Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.
Hogardt M, Heesemann J. Hogardt M, et al. Int J Med Microbiol. 2010 Dec;300(8):557-62. doi: 10.1016/j.ijmm.2010.08.008. Epub 2010 Oct 12. Int J Med Microbiol. 2010. PMID: 20943439 Review.
Cited by
- Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.
Maciá MD, Mena A, Borrell N, Pérez JL, Oliver A. Maciá MD, et al. Antimicrob Agents Chemother. 2007 Dec;51(12):4531-2. doi: 10.1128/AAC.00981-07. Epub 2007 Sep 24. Antimicrob Agents Chemother. 2007. PMID: 17893154 Free PMC article. No abstract available. - Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.
D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Déziel E, Smith EE, Nguyen H, Ernst RK, Larson Freeman TJ, Spencer DH, Brittnacher M, Hayden HS, Selgrade S, Klausen M, Goodlett DR, Burns JL, Ramsey BW, Miller SI. D'Argenio DA, et al. Mol Microbiol. 2007 Apr;64(2):512-33. doi: 10.1111/j.1365-2958.2007.05678.x. Mol Microbiol. 2007. PMID: 17493132 Free PMC article. - Epistatic roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in coping with reactive oxygen species-induced DNA damage.
Sanders LH, Devadoss B, Raja GV, O'Connor J, Su S, Wozniak DJ, Hassett DJ, Berdis AJ, Sutton MD. Sanders LH, et al. PLoS One. 2011 Apr 18;6(4):e18824. doi: 10.1371/journal.pone.0018824. PLoS One. 2011. PMID: 21533111 Free PMC article. - Interrelationship between type three secretion system and metabolism in pathogenic bacteria.
Wilharm G, Heider C. Wilharm G, et al. Front Cell Infect Microbiol. 2014 Oct 27;4:150. doi: 10.3389/fcimb.2014.00150. eCollection 2014. Front Cell Infect Microbiol. 2014. PMID: 25386411 Free PMC article. Review. - Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits cyclic AMP/Vfr signaling.
Jones AK, Fulcher NB, Balzer GJ, Urbanowski ML, Pritchett CL, Schurr MJ, Yahr TL, Wolfgang MC. Jones AK, et al. J Bacteriol. 2010 Nov;192(21):5709-17. doi: 10.1128/JB.00526-10. Epub 2010 Sep 3. J Bacteriol. 2010. PMID: 20817772 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous